专题：Hepatitis C virus research

This cluster of papers focuses on the epidemiology, treatment, and outcomes of hepatitis C virus infection. It covers topics such as antiviral therapy, genetic variation in viral clearance, global epidemiology, liver-related mortality, immune responses, and the impact of comorbidities like HIV and diabetes.
最新文献
Time-varying dynamics of hepatic steatosis and cardiometabolic risk: implications for posthepatitis C cure HCC risk

article Full Text OpenAlex

Liver Steatosis‐Related Polygenic Risk Score Predicts Hepatocellular Carcinoma Risk After Hepatitis C Virus Eradication

article Full Text OpenAlex

Mobile Telemedicine for Treating Chronic Hepatitis C Among Rural People Who Inject Drugs

article Full Text OpenAlex

Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease

article Full Text OpenAlex

Effect of Direct‐Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan

article Full Text OpenAlex

Advanced Fibrosis and Cardiometabolic Risk Burden Increase Major Cardiovascular Events in Chronic Hepatitis C Patients With Steatotic Liver Disease After Viral Eradication

article Full Text OpenAlex

Association between vitamin D and metabolic-associated steatotic liver disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis

article Full Text OpenAlex

Valacyclovir Treatment of Early Symptomatic Alzheimer Disease

article Full Text OpenAlex

Numerical computation of the stochastic hepatitis B model using feed forward neural network and real data

article Full Text OpenAlex

Individualising endpoints in chronic HBV treatment: HBsAg loss and beyond

article Full Text OpenAlex

近5年高被引文献
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

review Full Text OpenAlex 620 FWCI83.4039

Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

article Full Text OpenAlex 514 FWCI130.0306

Hepatitis B

review Full Text OpenAlex 493 FWCI107.1642

Global burden of hepatitis B virus: current status, missed opportunities and a call for action

review Full Text OpenAlex 489 FWCI106.6792

Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

article Full Text OpenAlex 487 FWCI70.4504

Corrigendum to ‘EASL recommendations on treatment of hepatitis C: Final update of the series’ [J Hepatol 73 (2020) 1170–1218]

erratum Full Text OpenAlex 451 FWCI19.8105

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

article Full Text OpenAlex 422 FWCI87.4622

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

article Full Text OpenAlex 358 FWCI77.7594

Changing epidemiology of hepatocellular carcinoma in Asia

review Full Text OpenAlex 324 FWCI49.4255

Challenges and opportunities in NASH drug development

review Full Text OpenAlex 318 FWCI71.6802